TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1985173

Group type: EXPERIMENTAL
Intervention: 4-Hydroperoxycyclophosphamide (4-HC) at 20 micrograms/mL
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 4-Hydroperoxycyclophosphamide (4-HC) at 40 micrograms/mL
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 4-Hydroperoxycyclophosphamide (4-HC) at 60 micrograms/mL
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 4-Hydroperoxycyclophosphamide (4-HC) at 80 micrograms/mL
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall treatment program
Number of subjects: 25
Study: 97718

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 31915040

Group type: EXPERIMENTAL
Intervention: 1 mg of tetracosactide intravenously over 20 min
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 0
Study: 30637882

Group type: COMPARATOR
Intervention: Fazekas 3 group
Number of subjects: 1454
Study: 28655802

Group type: EXPERIMENTAL
Intervention: Daily text messages containing simple medical facts or quiz questions
Number of subjects: 70
Study: 26340453

Group type: EXPERIMENTAL
Intervention: hf-TENS/thermotherapy device
Number of subjects: 115

Group type: COMPARATOR
Intervention: sham device
Number of subjects: 115
Study: 23892860

Group type: EXPERIMENTAL
Intervention: Educational materials provided to physicians
Number of subjects: 91
Study: 21287410

Group type: EXPERIMENTAL
Intervention: Bisoprolol treatment group
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo treatment group
Number of subjects: 340
Study: 19933935

Group type: EXPERIMENTAL
Intervention: Serum long-chain n-3 polyunsaturated fatty acids (PUFAs) - specifically eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid
Number of subjects: 2174

Group type: EXPERIMENTAL
Intervention: Serum docosahexaenoic acid
Number of subjects: 2174

Group type: EXPERIMENTAL
Intervention: Exclusion of subjects with myocardial infarction or congestive heart failure
Number of subjects: 2174

Group type: EXPERIMENTAL
Intervention: Serum intermediate chain-length n-3 PUFA, alpha-linolenic acid, or hair methylmercury concentration
Number of subjects: 2174
Study: 17301072

Group type: EXPERIMENTAL
Intervention: Tailored FEC (5-fluorouracil, epirubicin, cyclophosphamide)
Number of subjects: 525

Group type: COMPARATOR
Intervention: CTCb (cyclophosphamide, thiotepa, carboplatin)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Tailored FEC
Number of subjects: 525

Group type: COMPARATOR
Intervention: CTCb
Number of subjects: 525
Study: 16614584

Group type: EXPERIMENTAL
Intervention: Early extubation protocol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low anesthetic dose
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normothermic temperature management
Number of subjects: 27

Group type: COMPARATOR
Intervention: Fast-track treatment
Number of subjects: 27
Study: 12795460

Group type: EXPERIMENTAL
Intervention: IBS patients
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: IBS non-patients
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 51
Study: 10215471

Group type: EXPERIMENTAL
Intervention: 3D fast asymmetric spin echo (FASE) imaging
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3D fast spin echo (FSE) imaging
Number of subjects: 0
Study: 7767691

Group type: EXPERIMENTAL
Intervention: Multifactorial memory training (encoding operations, attentional functions, relaxation)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Multifactorial memory training
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 2216613

Group type: EXPERIMENTAL
Intervention: High-dose nebulized albuterol (0.30 mg/kg body weight)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard-dose nebulized albuterol (0.15 mg/kg body weight)
Number of subjects: 33
Study: 369923

Group type: EXPERIMENTAL
Intervention: Aldactone 100 mg daily
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acebutolol and Aldactone 200 mg daily
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combination of Aldactone and acebutolol
Number of subjects: 21
Study: 29061739

Group type: EXPERIMENTAL
Intervention: Rifabutin (300 mg/day, n=17)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg/day, n=16)
Number of subjects: 33
Study: 27355500

Group type: EXPERIMENTAL
Intervention: Feeding buddy program
Number of subjects: 625

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 625
Study: 22357166

Group type: EXPERIMENTAL
Intervention: IRO-A (15 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IRO-A with niacin (60 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Roxicodone (IRO) (15 mg)
Number of subjects: 40
Study: 23288372

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 4503

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 4503
Study: 20426584

Group type: EXPERIMENTAL
Intervention: Sandblasted acid-etched surface
Number of subjects: 7

Group type: COMPARATOR
Intervention: Machined surface
Number of subjects: 7
Study: 18534246

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study: 15810797

Group type: EXPERIMENTAL
Intervention: Iron-fortified milk (15 mg of iron per day per 400 ml)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Iron supplements (60 mg of iron per day)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168

Group type: COMPARATOR
Intervention: Nonfortified milk
Number of subjects: 168
Study: 11991533

Group type: EXPERIMENTAL
Intervention: Homogeneous enzyme immunoassay (EIA) for cotinine in urine
Number of subjects: 218

Group type: COMPARATOR
Intervention: Breath carbon monoxide measurement
Number of subjects: 218
Study: 10082055

Group type: EXPERIMENTAL
Intervention: Paremyd (0.25% tropicamide and 1.0% hydroxyamphetamine hydrobromide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapiprazole (Rev‐Eyes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paremyd with Dapiprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no dapiprazole)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapiprazole
Number of subjects: 0
Study: 8534463

Group type: EXPERIMENTAL
Intervention: Morphine plus scopolamine 0.25 mg via epidural catheter
Number of subjects: 50

Group type: COMPARATOR
Intervention: Morphine alone 2.5 to 4 mg via epidural catheter
Number of subjects: 50
Study: 2324256

Group type: EXPERIMENTAL
Intervention: Group A (daily monitoring from the 6th day of stimulation)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Group B (monitoring from the 11th day of stimulation)
Number of subjects: 108
Study: 7351723

Group type: EXPERIMENTAL
Intervention: 0.5 g cinoxacin at bedtime for 6 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 31146717

Group type: EXPERIMENTAL
Intervention: T-DM1 plus placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T-DM1 plus pertuzumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab plus taxane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T-DM1 (with or without pertuzumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HER2 mRNA expression and mutated PIK3CA
Number of subjects: 0
Study: 28445315

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops for 3 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Artificial tears (control)
Number of subjects: 62
Study: 26268408

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate
Number of subjects: 229
Study: 23381297

Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg once daily for 5 days
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 21822151

Group type: EXPERIMENTAL
Intervention: Unipedicular kyphoplasty (KP)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bipedicular kyphoplasty (KP)
Number of subjects: 50
Study: 19407810

Group type: EXPERIMENTAL
Intervention: Weight Wise Program (WWP)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 143
Study: 16972915

Group type: EXPERIMENTAL
Intervention: Osteoporosis educational programme
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study: 14593367

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) infused intravenously for 54.2±22.3 hours
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) enoxaparin 1 mg/kg b.i.d. subcutaneously for 76.2±28.3 hours
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group from randomized studies of thienopyridines in NSTEACS
Number of subjects: 18
Study: 11192133

Group type: EXPERIMENTAL
Intervention: Clarithromycin extended-release (two 500-mg tablets once daily for 7 days)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Clarithromycin immediate-release (one 500-mg tablet twice daily for 7 days)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Clarithromycin extended-release
Number of subjects: 620

Group type: COMPARATOR
Intervention: Clarithromycin immediate-release
Number of subjects: 620
Study: 9170464

Group type: EXPERIMENTAL
Intervention: Induction of labor (group I)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Expectant management (group II)
Number of subjects: 273
Study: 8251280

Group type: EXPERIMENTAL
Intervention: tropisetron 5 mg
Number of subjects: 54

Group type: COMPARATOR
Intervention: saline 5 ml (control)
Number of subjects: 54
Study: 3927342

Group type: EXPERIMENTAL
Intervention: Pentobarbital; specific doses not mentioned
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Barbital; specific doses not mentioned
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol; specific doses not mentioned
Number of subjects: 0
Study: 30531305

Group type: EXPERIMENTAL
Intervention: Low-dose Vitamin D3 (1000 IU)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Moderate-dose Vitamin D3 (3000 IU)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 30246286

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg/d
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (increased hypoglycemic dosage/addition of another hypoglycemic agent)
Number of subjects: 78
Study: 27364043

Group type: EXPERIMENTAL
Intervention: Fludrocortisone (0.05 mg to 0.2 mg daily)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 24862297

Group type: EXPERIMENTAL
Intervention: Oxytocin (OXT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Early life stress (ELS)
Number of subjects: 18
Study: 22569349

Group type: EXPERIMENTAL
Intervention: Milk (540 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Yogurt (540 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Milk
Number of subjects: 6
Study: 20425222

Group type: EXPERIMENTAL
Intervention: Multimodal neuroimaging (CT or MRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute and long-term treatment decisions based on neuroimaging results
Number of subjects: 0
Study: 18622778

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) group treatment for 10 weeks
Number of subjects: 347

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 347
Study: 16080635

Group type: EXPERIMENTAL
Intervention: Low Carbohydrates (LC) diet
Number of subjects: 71

Group type: COMPARATOR
Intervention: Low Fat (LF) diet
Number of subjects: 71
Study: 11981149

Group type: EXPERIMENTAL
Intervention: Controlled hypotension induced by sodium nitroprusside and hyperoxic ventilation (CH-100%; n = 14)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Controlled hypotension and ventilation with 50% O2 in nitrous oxide (CH-50%; n = 14)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard normotensive anesthesia with 50% O2 in nitrous oxide (control; n = 14)
Number of subjects: 42
Study: 10969685

Group type: EXPERIMENTAL
Intervention: Adenosine (140 microg x kg(‐1) x min(‐1) for 5 minutes)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (15 minutes of prearrest drug-free bypass)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 8794036

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine A (target trough levels 200 to 400 micrograms/L; group A; n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual cyclosporine dosage (target levels 400 to 600 micrograms/L; group B; n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine A (group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual cyclosporine dosage (group B)
Number of subjects: 30
Study: 1583085

Group type: EXPERIMENTAL
Intervention: Tablet formulation of tetroxoprim (100 mg) and sulphadiazine (250 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, assumed to be the other tablet formulation)
Number of subjects: 12
Study: 6706043

Group type: EXPERIMENTAL
Intervention: Chlorpropamide
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31235400

Group type: EXPERIMENTAL
Intervention: Rosehip seed oil (RHO) extract applied to 80 hands.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (56 hands).
Number of subjects: 68
Study: 30927953

Group type: EXPERIMENTAL
Intervention: Model A + B (histogram analysis combined with morphological characteristics)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Model A + B
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Entropy, microvascular sign, maximum diameter (independent predictors in IAC group)
Number of subjects: 289
Study: 28375708

Group type: EXPERIMENTAL
Intervention: 22,600-ppm fluoride varnish, toothbrush, 50-mL tube of 1,450 ppm fluoride toothpaste, and standardized, evidence-based prevention advice
Number of subjects: 1248

Group type: COMPARATOR
Intervention: Advice-only control
Number of subjects: 1248

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1248

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1248
Study: 25966108

Group type: EXPERIMENTAL
Intervention: tiaomian III decoction
Number of subjects: 61

Group type: COMPARATOR
Intervention: active immunotherapy with paternal lymphocytes (Control)
Number of subjects: 61
Study: 23689739

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 μg) plus oxytocin infusion (20 IU)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Intravenous carbetocin (100 μg)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol plus oxytocin infusion
Number of subjects: 380
Study: 20974289

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention based on the Diabetes Prevention Program (DPP)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Mass mailing recruitment strategy
Number of subjects: 301

Group type: COMPARATOR
Intervention: Mass mailing effectiveness
Number of subjects: 301

Group type: COMPARATOR
Intervention: Recruitment cost
Number of subjects: 301
Study: 17999781

Group type: EXPERIMENTAL
Intervention: Incredible Years group parenting programme combined with a new programme designed to train parents to support their children's reading at home
Number of subjects: 104
Study: 16424345

Group type: COMPARATOR
Intervention: rs2227631 A allele in nonsmokers
Number of subjects: 1853

Group type: COMPARATOR
Intervention: rs1799889 4G allele in nonsmokers
Number of subjects: 1853

Group type: COMPARATOR
Intervention: Haplotype A-4G-A-A-C in nonsmokers
Number of subjects: 1853
Study: 12568631

Group type: EXPERIMENTAL
Intervention: Rebamipide 300 mg/day
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 11152783

Group type: EXPERIMENTAL
Intervention: US-guided pneumatic reduction at 60 mm Hg for 30 seconds
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: US-guided pneumatic reduction at 120 mm Hg (for unreducible cases)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: US-guided pneumatic reduction
Number of subjects: 49
Study: 9244026

Group type: EXPERIMENTAL
Intervention: Modified Macintosh blade
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard Macintosh blade
Number of subjects: 46
Study: 8387421

Group type: EXPERIMENTAL
Intervention: Chest computed tomographic (CT) scan
Number of subjects: 103

Group type: COMPARATOR
Intervention: Fiberoptic bronchoscopy (FOB)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both FOB and CT scan
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: FOB
Number of subjects: 103
Study: 2880530

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5% dextrose in water (D5W)
Number of subjects: 40
Study: 2675812

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of cholestyramine and simvastatin
Number of subjects: 24
Study: 29190851

Group type: EXPERIMENTAL
Intervention: Exercise group (N=15) performed 60-min supervised treadmill exercise at moderate intensity (70% of HRmax) for 3 days per week for 4 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (N=12) did not exercise
Number of subjects: 27
Study: 28881182

Group type: EXPERIMENTAL
Intervention: Surgical staples
Number of subjects: 124

Group type: COMPARATOR
Intervention: Nonabsorbable monofilament sutures
Number of subjects: 124
Study: 23635890

Group type: EXPERIMENTAL
Intervention: Stainless steel piercings
Number of subjects: 80

Group type: COMPARATOR
Intervention: Polypropylene piercings
Number of subjects: 80

Group type: COMPARATOR
Intervention: Polytetrafluoroethylene piercings
Number of subjects: 80

Group type: COMPARATOR
Intervention: Other materials
Number of subjects: 80
Study: 22065795

Group type: EXPERIMENTAL
Intervention: Thyroid collar (TC) used during lateral cephalogram
Number of subjects: 100

Group type: COMPARATOR
Intervention: No thyroid collar (TC) used during lateral cephalogram
Number of subjects: 100
Study: 18261410

Group type: EXPERIMENTAL
Intervention: Surgery on the primary tumour
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy and radiotherapy
Number of subjects: 0
Study: 16507032

Group type: EXPERIMENTAL
Intervention: Traditional counselling by volunteer bereavement counsellors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Integrated intervention delivered by carers
Number of subjects: 0
Study: 15142026

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (1 set of 4-5 repetitions at 90% of 1RM)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Moderate-intensity resistance training (1 set of 10 repetitions at 70% of 1RM)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training (1 set of 15 repetitions at 50% of 1RM)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Session RPE measurement
Number of subjects: 19
Study: 11689034

Group type: EXPERIMENTAL
Intervention: Static color images of animals and vehicles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dynamic point-light displays of animals and vehicles
Number of subjects: 0
Study: 9204747

Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH) mRNA levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chromogranin A mRNA levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTH suppressibility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxyphilic parts of adenomas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium sensitivity
Number of subjects: 0
Study: 7952683

Group type: EXPERIMENTAL
Intervention: Portable biofeedback devices for treating oral dysphagia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient progress index (PPI)
Number of subjects: 0
Study: 3300758

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg orally
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 29331703

Group type: EXPERIMENTAL
Intervention: Vortioxetine (10mg/day)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Paroxetine (20mg/day)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 27456339

Group type: EXPERIMENTAL
Intervention: Non-pyrethroid insecticide-treated wall lining (ITWL) and universal coverage (UC) of long-lasting insecticidal nets (LLINs)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Universal coverage (UC) of long-lasting insecticidal nets (LLINs) alone
Number of subjects: 44
Study: 24985342

Group type: EXPERIMENTAL
Intervention: Promillekoll app (Group 1)
Number of subjects: 1932

Group type: EXPERIMENTAL
Intervention: PartyPlanner app (Group 2)
Number of subjects: 1932

Group type: COMPARATOR
Intervention: Control group (Group 3)
Number of subjects: 1932
Study: 21253739

Group type: EXPERIMENTAL
Intervention: Mechanical syringe technique
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional syringe technique
Number of subjects: 96
Study: 20413026

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Beta-blocker switches
Number of subjects: 51
Study: 18477494

Group type: EXPERIMENTAL
Intervention: Combination product (diaphragm and gel)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Single product (gel alone)
Number of subjects: 117
Study: 15730346

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1200 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Riluzole (100 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venlafaxine (150 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pramipexole (1.5 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12709522

Group type: EXPERIMENTAL
Intervention: Individualised smoking cessation intervention including minimal structured counselling (5‐8 minutes), nicotine patches for three months, and three sessions of counselling (2‐3 minutes) over a three month period.
Number of subjects: 217

Group type: COMPARATOR
Intervention: Standard clinical practice consisting of short (30 seconds to one minute) sporadic sessions of unstructured medical antismoking advice.
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Individualised smoking cessation intervention
Number of subjects: 217

Group type: COMPARATOR
Intervention: Standard clinical practice
Number of subjects: 217